Stocksigma LogoStocksigma Logo

Kimia Biosciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 2,681 (-21.1% YoY | +29.4% QoQ) ■ EBITDA: 458 (+81.7% YoY | +95.1% QoQ) ■ EBITDA Margin (%): 17.1 (+967 bps YoY | +575 bps QoQ) ■ PAT: 239

Kimia Biosciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Kimia Biosciences Ltd · Outcome · 13 Nov 2026, 10:12 pm

Kimia Biosciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 2,681 (-21.1% YoY | +29.4% QoQ) ■ EBITDA: 458 (+81.7% YoY | +95.1% QoQ) ■ EBITDA Margin (%): 17.1 (+967 bps YoY | +575 bps QoQ) ■ PAT: 239 (+135.2% YoY | +571.1% QoQ) ■ EPS (INR): 0.50 (+138.1% YoY | +525.0% QoQ)

Original exchange filing (PDF)

More announcements from Kimia Biosciences Ltd

All Kimia Biosciences Ltd announcements